---
$id: https://graph.org.ai/products/commodity/51131744
$type: Product
source: UNSPSC
code: "51131744"
title: "Argatroban anhydrous"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Argatroban anhydrous

**UNSPSC Code**: 51131744
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes the anhydrous form of an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IY90U61Z3S. European Medicines Agency schedules Argatroban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05559MIG. Argatroban generally arises in the molecular formula C23H36N6O5S. The term ARGATROBAN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 12 no. 1 1998, list 39.) ARGATROBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule argatroban anhydrous under HS 29350090. As of Q4 2014, ARGATROBAN ANHYDROUS remains US FDA's Preferred Term for this commodity. Argatroban anhydrous bears US NLM identifiers UMLS ID C2698183 and NCI Concept Code C75153. SMILES: C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)C2CCCC3C2NCC(C3)C.

